Nephronophthisis (NPH) and Senior-Loken syndrome (SLSN) |
Autosomal recessive |
NPHP1 (2q13) |
Nephrocystin-1 |
Hyperechogenic normal or small-sized kidneys with decreased corticomedullary differentiation |
INVS/NPHP2 (9q31.1) |
Inversin |
Tubulo-interstitial nephropathy |
NPHP3 (3q22.1) |
Nephrocystin-3 |
Polyuria, polydipsia, anemia |
NPHP4 (1p36.31) |
Nephrocystin-4 |
Senior-Loken syndrome: NPH + retinal dystrophy |
IQCB1/NPHP5 (3q13.33) |
IQCB1 |
CEP290/NPHP6 (12q21.32) |
CEP290 |
GLIS2/NPHP7 (16p13.3) |
GLIS2 |
RPGRIP1L/NPHP8 (16q12.2) |
RPGRIP1L |
NEK8/NPHP9 (17q11.2) |
NEK8 |
SDCCAG8/NPHP10 (1q43) |
SDCCAG8 |
TMEM67/NPHP11 (8q22.1) |
Meckelin |
TTC21B/NPHP12 (2q24.3) |
IFT139 |
XPNPEP3/NPHPL1 (22q13.2) |
XPNPEP3 |
Uromodulin-associated diseases: medullary cystic kidney disease (MCKD2), familial juvenile hyperuremic nephropathy (FJHN), glomerulocystic kidney disease (GCKD) |
Autosomal dominant |
UMOD (16p12.3) |
Uromodulin/Tamm-Horsfall protein |
Normal or reduced kidney volumen with usually small medullary or corticomedullary cysts |
Tubulo-interstitial nephropathy |
Hyperuricemia, gout |